HERO-Together: A post-Emergency Use Authorization observational cohort study to evaluate the safety of the Pfizer-BioNTech COVID-19 vaccine in US healthcare workers, their families, and their communities

17/12/2020
23/04/2024
EU PAS number:
EUPAS38671
Study
Finalised
Documents
Study protocol
Initial protocol
English (1.26 MB - PDF) View document
Updated protocol
English (648.39 KB - PDF) View document
Study results
Study results
English (6.3 MB - PDF) View document
Study report
Other information
Study, other information
English (3.17 MB - PDF) View document